Keytruda is made by the pharma company Merk and has fast become their best-selling drug. So high is the demand that Merk, known as MSD in Ireland, has changed their plans to close a manufacturing plant there.
The MSD plant in Swords, Dublin, which previously produced womens' health products, had been marked for closure since 2013, with a plan to gradually sundown the facility's 570 jobs and close the plant in 2017.
Merk put the plant on the market in 2017 but re-evaluated the plan once they realized that demand for Keytruda was not exceeding production.
Read More...